Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

I hope you're right, but they're not going to remove the late-stage from this press release as a surreptitious announcement that they're shelving Axal.

Look at the GERN debacle. JNJ telegraphed all the way up to the negative continuation decision that they regarded imetelstat as a key pillar of their heme portfolio. Then suddenly it wasn't anymore. That's how these companies operate; they're not going to put bread crumbs out there for observant shareholders to read.